Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
U.K.
Biotech
AbbVie invests £120M in UK, including expanded R&D site
AbbVie is investing 120 million pounds ($160 million) to expand its U.K. R&D presence, in a show of faith in the country’s life sciences sector.
James Waldron
Nov 4, 2026 2:31am
GSK plans ‘some limited impact’ to UK roles from restructuring
Oct 28, 2026 6:33am
Geopolitics ‘chills’ British biotech IPO plans, despite VC boost
Jul 20, 2026 7:45am
Fierce Biotech heading to UK amid London Life Sciences Week
Jun 11, 2026 4:57am
UK invests $64M to expand trials to underserved communities
Mar 4, 2026 10:51am
Cornerstone secures $200M to take its surgical robot global
Nov 18, 2025 9:45am
